Company: BLNE
Filing Date: 2025-08-18
Form Type: DEF 14A
Source: 0001641172-25-024627
Chunk: 38

Company: Beeline Holdings, Inc.
Filing Date: 2025-08-18
Form: DEF 14A
Chunk 38
---
 105 options, with a weighted-average exercise price of $304.30 per share, and 24,420 RSUs issued     
 under the 2016 Plan, with vesting schedules varying between immediate and three years from the grant date. The 2016 Plan is no longer 
 being used.                                                                                                                           |

Compensation Policies and Practices as Related to Risk Management

The Compensation Committee and management do not believe that the Company maintains compensation policies or practices that are reasonably likely to have a material adverse effect on the Company. Our employees’ base salaries are fixed in amount and thus we do not believe that they encourage excessive risk-taking. Our Compensation Committee has in the past granted and may in the future grant in its sole discretion equity awards to employees.

The principal risks other than liquidity relate to our ability to achieve operating profits and positive cash flow.

For information on certain grants which are subject to stockholder approval see the discussion under “Interests of Certain Parties” at page 29.

<div align='center'>PROPOSAL 3: APPROVAL OF THE INCREASE IN THE COMMON STOCK ISSUABLE UNDER OUR SERIES G CONVERTIBLE PREFERRED STOCK AND WARRANTS</div>

Overview

At the Annual Meeting stockholders will be asked to approve, for purposes of complying with Nasdaq Rule 5635(d), the issuance of shares of Common Stock underlying outstanding shares of Series G and Warrants in excess of the 1,650,000 shares of Common Stock (giving effect to a subsequent 1-for-10 reverse stock split) (the “Previously Approved Shares”) which were previously approved for issuance by the stockholders of the Company at the Special Meeting held on March 7, 2025 (the “Prior Meeting”). This Proposal is being brought before the stockholders to seek stockholder approval in accordance with Nasdaq rules of additional shares of Common Stock in excess of the Previously Approved Shares due to (i) additional sales and issuances of Series G and Warrants which occurred after the Prior Meeting, (ii) additional shares of Common Stock underlying the Series G and Warrants by virtue of certain price protection adjustments based on lower-priced sales of Common Stock by the Company which occurred after the Prior Meeting, and (iii) any further additional shares of Common Stock which may become issuable in the future by virtue of the price protection adjustment provisions set forth in the Series G and Warrants. The form of Warrant and Certificate of Designations of the Series G are relevant to an understanding of this Proposal and the Common Stock we may issue thereunder